A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 1,169 shares of AMGN stock, worth $369,404. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,169
Previous 739 58.19%
Holding current value
$369,404
Previous $210,000 73.81%
% of portfolio
0.02%
Previous 0.02%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$262.75 - $319.31 $112,982 - $137,303
430 Added 58.19%
1,169 $365,000
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $195,468 - $235,955
-727 Reduced 49.59%
739 $210,000
Q4 2023

Jan 31, 2024

SELL
$255.7 - $288.46 $8,949 - $10,096
-35 Reduced 2.33%
1,466 $422,000
Q3 2023

Nov 01, 2023

BUY
$218.65 - $271.46 $6,996 - $8,686
32 Added 2.18%
1,501 $403,000
Q2 2023

Jul 31, 2023

SELL
$214.27 - $253.37 $141,846 - $167,730
-662 Reduced 31.07%
1,469 $326,000
Q1 2023

May 01, 2023

SELL
$225.79 - $275.2 $12 Million - $14.6 Million
-53,048 Reduced 96.14%
2,131 $515,000
Q4 2022

Jan 31, 2023

SELL
$229.03 - $291.01 $3.12 Million - $3.97 Million
-13,642 Reduced 19.82%
55,179 $14.5 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $223,562 - $252,137
996 Added 1.47%
68,821 $15.5 Million
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $5.13 Million - $5.7 Million
22,219 Added 48.72%
67,825 $16.5 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $9.44 Million - $10.4 Million
43,037 Added 1675.24%
45,606 $11 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $159,104 - $182,080
800 Added 45.22%
2,569 $578,000
Q3 2021

Nov 10, 2021

SELL
$212.27 - $248.7 $275,314 - $322,563
-1,297 Reduced 42.3%
1,769 $376,000
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $261,376 - $289,977
1,119 Added 57.47%
3,066 $747,000
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $141,356 - $164,728
-637 Reduced 24.65%
1,947 $484,000
Q4 2020

Feb 16, 2021

BUY
$216.38 - $257.67 $432 - $515
2 Added 0.08%
2,584 $594,000
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $696,441 - $774,499
-2,968 Reduced 53.48%
2,582 $656,000
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $32,440 - $39,809
-164 Reduced 2.87%
5,550 $1.31 Million
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $146,520 - $194,326
-804 Reduced 12.34%
5,714 $1.16 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $357,228 - $459,161
1,888 Added 40.78%
6,518 $1.57 Million
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $806,129 - $965,910
4,630 New
4,630 $896,000
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $927,680 - $1.08 Million
-5,200 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $185,290 - $208,890
1,000 Added 23.81%
5,200 $1.08 Million
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $66,420 - $74,604
-400 Reduced 8.7%
4,200 $775,000
Q1 2018

May 14, 2018

BUY
$169.43 - $198.0 $372,746 - $435,600
2,200 Added 91.67%
4,600 $784,000
Q3 2017

Nov 09, 2017

BUY
$167.29 - $191.0 $401,496 - $458,400
2,400
2,400 $447,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.